Wednesday, June 23, 2021

Cipla gets USFDA nod for inhalation product

Cipla gets USFDA nod for inhalation product The company has received final approval for its abbreviated new drug application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL from the United States Food and Drug Administration (US FDA), Cipla said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/3vJOWKk
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

US equities end lower as valuation concerns creep in

U.S. stocks closed lower on Wednesday as investors took profits amid concerns about high valuations flagged by Fed Chair Powell. The market ...